05Aug 2023
Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox

Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox

Tecovirimat, previously effective against smallpox, is expected to combat monkeypox, and participants can choose between supportive treatment with tecovirimat or supportive treatment only. The primary endpoint is the percentage of patients with negative PCR results for skin lesions after 14 days. Secondary endpoints include mortality at 14 and 30 days, viral load, fever duration, and adverse events.

  • #family health

Like

Save

Share